The Lombardi Atrium is now open and valet parking services are available.
Georgetown Lombardi Comprehensive Cancer Center clinicians are dedicated to providing the best professional care, delivered with compassion, for all patients.
Georgetown Lombardi's seeks to prevent, treat, and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community; guided by the principle of cura personalis, "care for the whole person. Georgetown Lombardi's research program includes innovative clinical trials like the one that Melanoma Cancer Survivor, Leta Brown, participated in.
Leta Brown of Maryland was only 43 when she was diagnosed with advanced metastatic melanoma in 2013. She sought treatment at MedStar Georgetown University Hospital where she enrolled in a clinical trial of two immunotherapy agents, nivolumab (Opdivo) and ipilimumab (Yervoy) through Georgetown University's Lombardi Comprehensive Cancer Center. Within weeks her cancer began to shrink. Today she is cancer free. Leta's treatment regimen for advanced melanoma is now FDA approved.